BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., announced the appointment of veteran public company operator John P. Gorst as Chief Executive Officer, effective immediately. The leadership change comes as the company advances toward the anticipated closing of its previously announced acquisition of Ancient Extracts USA and pursues broader platform expansion initiatives.
Jordan P. Balencic, who previously served as CEO, will remain Chairman of the Company and transition into the role of Chief Science Officer. In this new capacity, Balencic will focus on strategic growth initiatives, acquisition strategy, product development, commercialization opportunities, and the company's long-term platform vision.
Mr. Gorst brings more than 30 years of experience across public company leadership, consumer products, manufacturing, operational scaling, direct-to-consumer growth, strategic partnerships, and capital markets. Throughout his career, he has participated in raising more than $100 million through equity financings, PIPE transactions, debt offerings, and strategic growth initiatives. Management noted that Mr. Gorst has successfully participated in two separate eight-figure business exits and several smaller exits.
Management expects Mr. Gorst to play a major role in operational execution, acquisition integration, commercialization strategy, strategic partnerships, fundraising efforts, and expansion of the company's broader wellness platform strategy. In connection with his appointment, Mr. Gorst is also expected to join the company's Board of Directors as BFCH continues expanding its operational and corporate governance infrastructure.
The appointment comes as BFCH works toward finalizing definitive agreements related to the acquisition of Ancient Extracts USA, a post-revenue wellness platform with an established direct-to-consumer infrastructure, growing customer base, expanding product portfolio, active commercialization initiatives, and revenue-generating operations. Management also expects to begin announcing initial purchase orders and additional commercial developments following the anticipated closing as Ancient Extracts USA continues scaling operations, expanding distribution initiatives, and pursuing broader retail opportunities.
"What excites me most is how naturally all of this fits together," said Dr. Balencic. "Ancient Extracts USA already has a commercial foundation in place, and Mr. Gorst brings decades of operational, manufacturing, consumer products, and capital markets experience. Our skill sets complement each other extremely well, and we are already identifying multiple opportunities to expand the platform, create strategic synergies, and accelerate growth across several areas of the business."
Dr. Balencic continued: "This is not about a single acquisition. We are building a scalable operating platform focused on consumer wellness, commercialization, and strategic growth opportunities. As we continue adding infrastructure, strategic relationships, and complementary operating assets, we believe the long-term opportunity becomes significantly larger."
Mr. Gorst added: "What attracted me to BFCH is that this is more than a turnaround story. Ancient Extracts USA already has products, customers, revenue, infrastructure, and momentum in place. I believe there is a significant opportunity to scale the platform through disciplined execution, expanded distribution, strategic partnerships, and additional operating assets. I'm excited to help build the next phase of growth."
Mr. Gorst will also immediately initiate the formation of audit and compensation committees as part of a broader effort to enhance the company's corporate governance infrastructure, prepare for future audits, support the expansion of the Board of Directors, and continue recruiting experienced C-level executive leadership. The company also confirmed that management intends to work with legal counsel and the Board of Directors to further align executive employment agreements and compensation structures with long-term operational execution, platform growth, and shareholder value creation objectives.
The company also confirmed it continues actively evaluating additional acquisition opportunities, strategic partnerships, and operating assets aligned with its broader long-term strategy focused on consumer wellness, functional products, human optimization, and performance-focused infrastructure. For more corporate information, visit www.UNLOCKDinc.com. View current filings on OTC Markets at https://www.otcmarkets.com.
